Evan Rosen, MD, PhD, Named Chief of Endocrinology, Diabetes and Metabolism at Beth Israel Deaconess Medical Center
Chloe Meck (BIDMC Communications) 617-667-7367, firstname.lastname@example.org
MAY 15, 2018
BOSTON – Evan Rosen, MD, PhD, has been named Chief of the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine at Beth Israel Deaconess Medical Center (BIDMC). Previously Program Director for the joint BIDMC and Joslin Diabetes Center Fellowship in Endocrinology and Metabolism, Rosen has built a strong foundation in research and education at BIDMC for more than a decade.
“Dr. Rosen is an outstanding physician-scientist and mentor, and we are very pleased to welcome him into this new role,” said Mark Zeidel, MD, Chairman of the Department of Medicine at BIDMC. “He represents a fitting new chapter in leadership of the division, which has featured giants in the field of endocrinology and academic medicine.”
Also a Professor of Medicine at Harvard Medical School and an Institute Member of the Broad Institute of Harvard and the Massachusetts Institute of Technology, Rosen leads a laboratory at BIDMC that focuses on the transcriptional pathways that underlie metabolic diseases like obesity and Type 2 diabetes. In particular, his research has used genomic and epigenomic approaches to identify novel pathways that regulate how fat cells are formed, how they behave in normal health and how they become dysfunctional in metabolic disease.
“This division has been my professional home for the past 17 years, and I have been consistently impressed and amazed by the outstanding clinical care, training and research that emerges from this place,” said Rosen. “I am very gratified that the Department of Medicine and BIDMC have made significant commitments to preserve and expand upon the legacy of excellence left behind by my predecessors.”
Rosen earned his medical degree and his doctorate in Cellular and Molecular Biology from the University of Michigan. He completed his residency in Internal Medicine at Brigham and Women’s Hospital and separate fellowship programs with Massachusetts General Hospital and Dana-Farber Cancer Institute. Rosen is board certified in Internal Medicine and Endocrinology.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.